Latest Insider Transactions at Pulmonx Corp (LUNG)
This section provides a real-time view of insider transactions for Pulmonx Corp (LUNG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Pulmonx Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Pulmonx Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Derrick Sung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+10.8%
|
-
|
|
Mar 01
2022
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
458
-0.2%
|
$11,450
$25.91 P/Share
|
|
Feb 18
2022
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
12,500
-0.58%
|
$325,000
$26.97 P/Share
|
|
Feb 17
2022
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
12,500
-1.15%
|
$337,500
$27.22 P/Share
|
|
Jan 21
2022
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
12,500
-0.38%
|
$300,000
$24.56 P/Share
|
|
Jan 20
2022
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
12,500
-1.12%
|
$312,500
$25.98 P/Share
|
|
Dec 16
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-1.1%
|
$775,000
$31.33 P/Share
|
|
Dec 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
22,000
-7.58%
|
$682,000
$31.01 P/Share
|
|
Dec 15
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.66%
|
$93,000
$31.05 P/Share
|
|
Dec 14
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.3%
|
$96,000
$32.89 P/Share
|
|
Dec 01
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
383
-0.17%
|
$12,256
$32.73 P/Share
|
|
Dec 01
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
355
-0.24%
|
$11,360
$32.73 P/Share
|
|
Dec 01
2021
|
David Aaron Lehman GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
383
-2.22%
|
$12,256
$32.73 P/Share
|
|
Dec 01
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
1,421
-0.12%
|
$45,472
$32.73 P/Share
|
|
Nov 18
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-0.56%
|
$900,000
$36.51 P/Share
|
|
Nov 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.58%
|
$273,000
$39.94 P/Share
|
|
Oct 21
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-1.09%
|
$975,000
$39.81 P/Share
|
|
Oct 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.38%
|
$273,000
$39.44 P/Share
|
|
Sep 21
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.28%
|
$111,000
$37.5 P/Share
|
|
Sep 20
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.63%
|
$111,000
$37.65 P/Share
|
|
Sep 20
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
23,571
-96.39%
|
$872,127
$37.66 P/Share
|
|
Sep 16
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-2.12%
|
$950,000
$38.86 P/Share
|
|
Sep 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.2%
|
$266,000
$38.12 P/Share
|
|
Sep 01
2021
|
Alissa Hsu Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,610
+50.0%
|
-
|
|
Sep 01
2021
|
Tiffany Sullivan |
BUY
Grant, award, or other acquisition
|
Direct |
4,610
+50.0%
|
-
|
|
Sep 01
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
1,421
-0.12%
|
$56,840
$40.09 P/Share
|
|
Sep 01
2021
|
David Aaron Lehman GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
383
-2.18%
|
$15,320
$40.09 P/Share
|
|
Sep 01
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
355
-0.21%
|
$14,200
$40.09 P/Share
|
|
Sep 01
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
383
-0.16%
|
$15,320
$40.09 P/Share
|
|
Aug 19
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-2.07%
|
$900,000
$36.63 P/Share
|
|
Aug 19
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-4.07%
|
$36,000
$36.59 P/Share
|
|
Aug 16
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.03%
|
$252,000
$36.71 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-1.31%
|
$38,000
$38.21 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-0.68%
|
$950,000
$38.4 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+0.35%
|
$8,750
$2.2 P/Share
|
|
Jul 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-1.3%
|
$266,000
$38.56 P/Share
|
|
Jul 13
2021
|
Boston Scientific Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,500,000
-62.69%
|
$92,500,000
$37.45 P/Share
|
|
Jul 12
2021
|
Daniel P Florin |
BUY
Open market or private purchase
|
Direct |
2,500
+24.92%
|
$100,000
$40.0 P/Share
|
|
Jun 25
2021
|
Daniel P Florin |
BUY
Open market or private purchase
|
Direct |
2,222
+30.63%
|
$97,768
$44.12 P/Share
|
|
Jun 17
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-3.76%
|
$42,000
$42.68 P/Share
|
|
Jun 17
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-1.0%
|
$1,075,000
$43.15 P/Share
|
|
Jun 17
2021
|
Glendon E. French Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+0.35%
|
$8,750
$2.2 P/Share
|
|
Jun 01
2021
|
Thomas William Burns |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+50.0%
|
-
|
|
Jun 01
2021
|
Richard Ferrari |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+12.89%
|
-
|
|
Jun 01
2021
|
Daniel P Florin |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+50.0%
|
-
|
|
Jun 01
2021
|
Glendon E. French Iii |
BUY
Grant, award, or other acquisition
|
Direct |
45,600
+3.53%
|
-
|
|
Jun 01
2021
|
David Aaron Lehman GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
17,600
+50.0%
|
-
|
|
Jun 01
2021
|
Dana G Mead Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+8.8%
|
-
|
|
Jun 01
2021
|
Georgia Melenikiotou |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+50.0%
|
-
|
|
Jun 01
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,600
+8.87%
|
-
|